Change in the inflammatory markers: Low-grade inflammation, which is related to elevated production of inflammatory cytokines like tumor necrosis factor (TNF), interleukin 6 (IL-6), and leptin, is one of the typical pathways of the onset of IR in DM patients. This evidence concerns the gene TNF and diabetes mellitus.